4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001662579-24-000030
Options or other derivatives
- Chief Scientific Officer acquired 212,950 shares (grant or award)
- Chief Scientific Officer returned 212,950 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Fisher Stewart · Chief Scientific Officer
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-07 | Returned to the company : show line 1 in the form Stock Option (Right to Buy) | −94,950 | 0 | D |
| 2024-03-07 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +94,950 | 94,950 | D |
| 2024-03-07 | Returned to the company : show line 3 in the form Stock Option (Right to Buy) | −118,000 | 0 | D |
| 2024-03-07 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +118,000 | 118,000 | D |
Loading xslF345X05/wk-form4_1709943962.xml…